Uncategorized

Rival weight loss drugs go head-to-head with clear winner – BBC

Posted on Author Tim Hodges Comments Off on Rival weight loss drugs go head-to-head with clear winner – BBC
  1. Rival weight loss drugs go head-to-head with clear winner  BBC
  2. Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs  NBC News
  3. Eli Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy in Study  Bloomberg.com
  4. Eli Lilly looks set to steal Novo Nordisk’s weight-loss crown  The Economist
  5. Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine  Eli Lilly and Company